US State Department approves possible sale to Australia of fighter jet spare parts, World News
WASHINGTON — The US State Department approved a possible foreign military sale to Australia of fighter jet spare parts for US$2 billion (S$2.56 billion), the Pentagon said in a statement, adding the principle contractor will be Boeing.
Australia had requested to buy the equipment related to the sustainment of its Boeing F/A-18F Super Hornet fighter jet, and the EA-18G Growler jet which is mainly used in electronic warfare roles such as radar jamming.
[[nid:719165]]
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Times
an hour ago
- Business Times
Thailand Cabinet approves 40 billion baht bid to host Formula 1 race in 2028
[BANGKOK] Thailand's Cabinet has approved a US$1.2 billion bid to host a Formula One street race in its capital Bangkok in 2028, government officials said on Tuesday (Jun 17). If successful, the Thai capital would win a contract to host a race each year from 2028 to 2032, government spokesperson Jirayu Houngsub told a news conference. 'In the next 2 to 3 years, Thailand will have world-class competition, which we never thought would actually happen in Thailand,' Jirayu said. Tourism Minister Sorawong Thienthong told reporters the bid is worth about 40 billion baht (S$1.6 billion). In March, Thai Prime Minister Paetongtarn Shinawatra met with Formula One chief Stefano Domenicali and said Thailand would commission a feasibility study into hosting a Grand Prix on a Bangkok street circuit from 2028. Hosting the race will help promote tourism, a key driver of Thailand's economy, the government has said. Formula One already has a crowded schedule of 24 races around the world with four in the Asia-Pacific region, including the Singapore Grand Prix in South-east Asia. Thailand has an FIA-accredited track in Buriram in the northeast of the country, which currently hosts a round of the MotoGP motorcycling world championships, but the proposal is for a street race in the kingdom's capital. REUTERS
Straits Times
an hour ago
- Straits Times
Thai cabinet approves US$1.2 billion bid to host Formula 1 race in 2028
General view of the F1 logo ahead of the Monaco Grand Prix. BANGKOK – Thailand's cabinet has approved a US$1.2 billion (S$1.5 billion) bid to host a Formula One street race in its capital Bangkok in 2028, government officials said on June 17. If successful, the Thai capital would win a contract to host a race each year from 2028 to 2032, government spokesperson Jirayu Houngsub told a news conference. 'In the next two to three years, Thailand will have world-class competition, which we never thought would actually happen in Thailand,' Jirayu said. Tourism Minister Sorawong Thienthong told reporters the bid is worth about 40 billion baht (US$1.23 billion). In March, Thai Prime Minister Paetongtarn Shinawatra met with Formula One chief executive Stefano Domenicali and said that Thailand would commission a feasibility study into hosting a Grand Prix on a Bangkok street circuit from 2028. Hosting the race will help promote tourism, a key driver of Thailand's economy, the government has said. Formula One already has a crowded schedule of 24 races around the world with four in the Asia-Pacific region, including the Singapore Grand Prix at the Marina Bay circuit in South-east Asia. Thailand has an FIA-accredited track in Buriram in the north-east of the country, which currently hosts a round of the MotoGP motorcycling world championships, but the proposal is understood to be solely for a street race in the kingdom's capital. Ms Paetongtarn had previously said on social media following the talks with Domenicali: 'Thailand sees the opportunity to host a Formula One Grand Prix in the future as a key initiative to elevate our profile as a hub for international tourism and global events.' Thailand has representation on track via Thai driver Alexander Albon of Williams, who is eighth in the drivers' standings on 42 points – but he has yet to win a race or be on the podium this season. Neighbouring Vietnam was set to make its F1 debut in 2020 but the inaugural Vietnamese Grand Prix was cancelled because of the Covid-19 pandemic, and Hanoi has not appeared on the race calendar since. The country inked a 10-year deal – costing US$60 million a year – with F1 in 2018, betting that the glamour of the sport could reshape Hanoi's staid image and reflect the country's economic lift-off. But after the 2020 cancellation, the race was dropped from the 2021 calendar when city mayor Nguyen Duc Chung, a major supporter of the GP, was arrested. In January 2024, it was reported that Malaysia's state oil company Petronas was looking to bring back F1 races to the country in 2026 after a nine-year hiatus. Malaysia hosted a grand prix at its Sepang International Circuit from 1999, but staged its last race in 2017 due to declining ticket sales and rising costs. REUTERS, BLOOMBERG Join ST's Telegram channel and get the latest breaking news delivered to you.
Straits Times
an hour ago
- Straits Times
Nasdaq-listed herbal medicine stock with no sales rallies 64,000%
The unbelievable rally has transformed Regencell Bioscience Holdings, a penny stock as recently as April, to one worth more than US$20 billion (S$25.6 billion) in market value. PHOTO: ST FILE NEW YORK - A Nasdaq-listed stock focused on herbal medicine has spiked by more than 64,000 per cent so far in 2025 and yet, the company itself has made zero revenue – much less turned a profit. The unbelievable rally has transformed Regencell Bioscience Holdings, a penny stock as recently as April, to one worth more than US$20 billion (S$25.6 billion) in market value. A year ago, the stock had a market capitalisation of just US$53 million. This is despite the company having a net loss of US$4.4 million for its fiscal year that ended June 2024, a 28 per cent decrease from the previous year. Earlier in June the company said its board approved a 38-for-1 stock split. When the split took effect on June 16, shares soared as much as 434 per cent – their biggest one-day jump ever – to a record high, triggering more than 10 volatility halts. Shares of the company have been on a bizarre, 640-fold tear in 2025, with little to no news from the firm. The Hong Kong-based firm, which debuted on the Nasdaq Capital Market in 2021, is in the research and development stage and has not generated any revenue since inception, according to its most-recent annual filing with the US Securities and Exchange Commission (SEC). A representative for Regencell didn't immediately respond to a Bloomberg News request for comment. Incorporated in the Cayman Islands, the firm aims to treat neurological disorders like ADHD and autism spectrum disorder through traditional herb-based medicines, according to its website. Its traditional Chinese medicine (TCM) formula, which forms the basis of its product candidates, 'contains only natural ingredients without any synthetic components.' 'We have not generated revenue from any TCM formulae candidates or applied for any regulatory approvals, nor have distribution capabilities or experience or any granted patents or pending patent applications and may never be profitable,' the company said in an October filing. The company also made its foray into treatments for Covid-19, conducting trials in 2022 for an 'holistic approach' with its experimental therapy. Regencell said data from a 2022 trial showed the treatment was effective in reducing and eliminating Covid symptoms within six days, although the results were yet to be peer-reviewed. The firm has funded its operations so far, primarily from shareholder loans and proceeds from its initial public offering, the SEC filing showed. It said its gross proceeds from its IPO were US$21.85 million, with additional net proceeds of US$2.85 million from the issue of the over allotment shares and exercise of 325,000 shares. One potential reason for the outsized swings in Regencell shares: its tiny float. Of its nearly 500 million outstanding shares, only about 30 million are available to be traded. That equates to roughly 6 per cent of shares, compared to Apple – which has about 98 per cent available – and Tesla's 87 per cent. Insiders own the remaining Regencell shares, with chief executive officer Yat-Gai Au's ownership accounting for 86 per cent, according to holding data compiled by Bloomberg. BLOOMBERG Join ST's Telegram channel and get the latest breaking news delivered to you.
